Status:

COMPLETED

Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris

Lead Sponsor:

Zagazig University

Conditions:

Acne Vulgaris

Eligibility:

All Genders

16-40 years

Brief Summary

* To evaluate and compare the anti-biofilm activity of Salicylic acid, Isotretinoin, and N-acetylcysteine against C. acne . * To assess the possible role of Salicylic acid, Isotretinoin, and N-acetylc...

Detailed Description

The study was carried out on 24 patients with acne vulgaris. They were recruited from the outpatient clinic of the Dermatology and Venereology and Andrology Department, Zagazig University Hospitals, E...

Eligibility Criteria

Inclusion

  • Adult Patients.
  • Patients of both sexes.
  • Patients with acne vulgaris with different grades

Exclusion

  • Patients received topical or oral treatment within 6 weeks prior to microbiological sampling

Key Trial Info

Start Date :

March 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2024

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT06179056

Start Date

March 1 2023

End Date

February 1 2024

Last Update

April 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Reham Essam

Zagazig, Al Sharqia, Egypt, 2543